Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest
Caroline D. Scatena , Zoe A. Stewart , Deborah Mays , Luo Jia Tang
Journal of Biological Chemistry 273 ( 46) 30777 -30784
207
1998
Stabilization and Functional Impairment of the Tumor Suppressor p53 by the Human Papillomavirus Type 16 E7 Oncoprotein
Alexandra Eichten , Matthew Westfall , Jennifer A. Pietenpol , Karl Münger
Virology 295 ( 1) 74 -85
81
2002
Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer
Michael E. Feigin , S. Dipikaa Akshinthala , Kiyomi Araki , Avi Z. Rosenberg
Cancer Research 74 ( 11) 3180 -3194
75
2014
p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton
Sandra Fuertes-Alvarez , Laura Maeso-Alonso , Javier Villoch-Fernandez , Merit Wildung
Cell Death and Disease 9 ( 12) 1183
13
2018
Interferon α/β modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts
Jennifer A. Pietenpol , Philip H. Howe , Muriel R. Cunningham , Edward B. Leof
Journal of Cellular Physiology 141 ( 3) 453 -460
3
1989
Constitutively Active K-cyclin/cdk6 Kinase in Kaposi Sarcoma–Associated Herpesvirus–Infected Cells
Rukiyah Van Dross , Shan Yao , Shaheena Asad , Grant Westlake
Journal of the National Cancer Institute 97 ( 9) 656 -666
31
2005
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.
Andrew J. Wilson , Oluwole Fadare , Alicia Beeghly-Fadiel , Deok-Soo Son
Oncotarget 6 ( 25) 21353 -21368
34
2015
A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF-β signaling
Kimberly A. Brown , Jennifer A. Pietenpol , Harold L. Moses
Journal of Cellular Biochemistry 101 ( 1) 9 -33
426
2007
Cell cycle checkpoints as therapeutic targets.
Zoe A. Stewart , Jennifer A. Pietenpol
Journal of Mammary Gland Biology and Neoplasia 4 ( 4) 389 -400
25
1999
p53 family members: similar biochemistry, different biology.
Christopher E. Barbieri , Jennifer A. Pietenpol
Cancer Biology & Therapy 4 ( 4) 419 -420
5
2005
A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-term outcome correlated with increased frequency of DNA damage response gene mutations, TNBC subtype, AR status, and Ki67
Bojana Jovanović , Ingrid A. Mayer , Erica L. Mayer , Vandana G. Abramson
Clinical Cancer Research 23 ( 15) 4035 -4045
97
2017
BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition
Katherine E. Hutchinson , Doron Lipson , Philip J. Stephens , Geoff Otto
Clinical Cancer Research 19 ( 24) 6696 -6702
115
2013
A gene signature-based approach identifies mTOR as a regulator of p73.
Jennifer M. Rosenbluth , Deborah J. Mays , Maria F. Pino , Luo Jia Tang
Molecular and Cellular Biology 28 ( 19) 5951 -5964
91
2008
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann , Bojana Jovanović , Xi Chen , Monica V. Estrada
PLOS ONE 11 ( 6) e0157368
1,022
2016
Evaluation of p63 and p73 antibodies for cross-reactivity.
Jennifer M. Rosenbluth , Kimberly Johnson , Luojia Tang , Tracy Triplett
Cell Cycle 8 ( 22) 3702 -3706
23
2009
Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer.
Fei Wang , Wei Zheng , Christina E. Bailey , Ingrid A. Mayer
Cancer Research 81 ( 4) 1163 -1170
2021
Apoptosis of Late-Stage Erythroblasts in Megaloblastic Anemia: Association With DNA Damage and Macrocyte Production
Mark J. Koury , Donald W. Horne , Zoe A. Brown , Jennifer A. Pietenpol
Blood 89 ( 12) 4617 -4623
75
1997
p73 regulates epidermal wound healing and induced keratinocyte programming.
J. Scott Beeler , Clayton B. Marshall , Paula I. Gonzalez-Ericsson , Timothy M. Shaver
PLOS ONE 14 ( 6)
4
2019
TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer
Brian D. Lehmann , Vandana G. Abramson , Melinda E. Sanders , Erica L. Mayer
Clinical Cancer Research 26 ( 9) 2111 -2123
84
2020
IGFBP-3 Is a Direct Target of Transcriptional Regulation by ΔNp63α in Squamous Epithelium
Christopher E. Barbieri , Carmen A. Perez , Kimberly N. Johnson , Kim A. Ely
Cancer Research 65 ( 6) 2314 -2320
70
2005